Alan Forrest Memorial Fund

Alan Forrest.

Named after a longtime faculty member, this fund will provide research support for PharmD students.

Dr. Alan Forrest was a faculty member and research professor in the School of Pharmacy and Pharmaceutical Sciences. He was renowned in the field of antimicrobial pharmacokinetics, pharmacodynamics and toxicodynamics (PK/PD/TD), and served as a researcher and educator for almost 40 years before he passed away in 2018.

This fund is designed to create an endowed research scholarship for students in UB’s doctor of pharmacy (PharmD) program.

During his career, Dr. Forrest held a number of prestigious faculty positions at UB, worked as the Senior Director of Pharmacometrics at the Institute for Clinical Pharmacodynamics, and was also an expert adviser to the Food and Drug Administration and the pharmaceutical industry.

His research primarily focused on aspects of translational medicine within the fields of anti-infectives and oncology. As a result of his work, exposure response analyses for antimicrobials have become standard practice in translational drug development.

In addition to mentoring more than 100 trainees and fellows, Dr. Forrest received numerous awards, and always maintained his focus on improving the care of patients.

Make a Difference Now

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • Sprowl receives NIDCD/NIH grant to study protein’s role in preventing drug-induced hearing loss
    6/5/23
    Jason Sprowl, PhD, assistant professor, Department of Pharmaceutical Sciences, has been awarded a $432,182 grant from National Institute on Deafness and Other Communication Disorders (NIDCD) and the National Institutes of Health (NIH). The study, called “Role of MCT6 in mediating cisplatin-induced ototoxicity,” will help researchers understand and prevent a prevalent type of drug-induced hearing loss in cancer patients.
  • Team Alice, UB’s study of medication harm in older adults, receives $1.95 million national grant
    11/15/23

    Funding to support interdisciplinary research into older patients’ journey throughout health care system

  • UB SPPS hosts Ann E. Weber, PhD, as 2023 David Chu lecturer
    5/9/23
    On May 8, the University of Buffalo School of Pharmacy and Pharmaceutical Sciences (UB SPPS) welcomed Ann E. Weber, PhD, senior vice president, Research and Development, Kallyope Inc., as our 2023 David Chu Lecturer.
  • Seyse recognized as 2023 AACP Distinguished Preceptor
    5/30/23
    Stephanie Seyse, PharmD, adjunct assistant professor, Department of Pharmacy Practice and Internal Medicine Pharmacist, Buffalo General Medical Center, has been recognized as a 2023 Distinguished Preceptor by the American Association of Colleges of Pharmacy (AACP).
  • Anadi named inaugural UB SPPS PAL Fellow
    6/16/23
    Ijeoma (EJ) Anadi, PharmD ’23, MS ’22, has been named the inaugural fellow for the UB School of Pharmacy and Pharmaceutical Sciences (SPPS) Pharmacy Academic and Leadership (PAL) Fellowship program. 
  • UB faculty, staff receive SUNY Chancellor’s Awards
    6/7/23

    Twenty have been recognized for consistently superior professional achievement and the ongoing pursuit of excellence.

  • UB Center for Integrated Global Biomedical Sciences selected to host Zimbabwe Emerging Faculty Development Program
    5/18/23
    The University at Buffalo, State University of New York (UB SUNY) has been selected to be the United States host for the Zimbabwe Emerging Faculty Development Program (ZEFDP). Through a grant funded by the U.S. Department of State to the Institute of International Education, a global non-profit organization facilitating international exchange, the program will bring nine faculty from different universities in Zimbabwe to UB for six weeks beginning in early June 2023. The programmatic areas include biomedical research, pharmacy, university administration, public health, and sustainable development.